Instituto de Investigación Biomédica de A Coruña (INIBIC)
Centro de investigación
Publicaciones en las que colabora con Eva Poveda López (41)
2024
-
Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain
AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314
-
Should we measure quality of life among people with HIV? A multicentre survey of physicians' opinions in Spain
HIV Medicine
2022
-
Discovering HIV related information by means of association rules and machine learning
Scientific Reports, Vol. 12, Núm. 1
-
Massive Release of CD9+ Microvesicles in Human Immunodeficiency Virus Infection, Regardless of Virologic Control
The Journal of infectious diseases, Vol. 225, Núm. 6, pp. 1040-1049
-
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort
HIV Medicine, Vol. 23, Núm. 8, pp. 825-836
2021
-
COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study
HIV Medicine, Vol. 22, Núm. 9, pp. 867-876
2020
-
Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study
The Lancet HIV, Vol. 7, Núm. 8, pp. e565-e573
-
How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain
HIV Medicine, Vol. 21, Núm. 2, pp. 128-134
2019
-
Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines
Journal of the International Association of Providers of AIDS Care, Vol. 18
2018
-
Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients
Medicine (United States), Vol. 97, Núm. 38
-
Initial treatment response among HIV subtype F infected patients who started antiretroviral therapy based on integrase inhibitors
AIDS, Vol. 32, Núm. 1, pp. 121-125
-
Low-level viremia is associated with clinical progression in HIV-infected patients receiving antiretroviral treatment
Journal of Acquired Immune Deficiency Syndromes, Vol. 78, Núm. 3, pp. 329-337
-
Prevalence of NS5A resistance associated substitutions in patients with hepatitis C virus genotypes 1a and 3: Impact on current therapeutic strategies
Journal of Medical Virology, Vol. 90, Núm. 6, pp. 1094-1098
2017
-
Cancer incidence in persons living with HIV
Clinical Infectious Diseases
-
Characterization of chronic HCV infection in Northwest Spain: Impact of the treatment strategic plan of the Spanish National Health Service on HCV cure
Journal of Medical Virology, Vol. 89, Núm. 7, pp. 1304-1308
-
Clinical Experience with the Integrase Inhibitors Dolutegravir and Elvitegravir in HIV-infected Patients: Efficacy, Safety and Tolerance
Basic and Clinical Pharmacology and Toxicology, Vol. 121, Núm. 5, pp. 442-446
-
Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study
HIV Medicine, Vol. 18, Núm. 7, pp. 482-489
-
Increased incidence of cancer observed in HIV/hepatitis C virus-coinfected patients versus HIV-monoinfected
AIDS, Vol. 31, Núm. 8, pp. 1099-1107
-
Liver-related mortality and hospitalizations attributable to chronic hepatitis C virus coinfection in persons living with HIV
HIV Medicine, Vol. 18, Núm. 9, pp. 685-689
-
Nuevos modelos para una educación científica inclusiva a través de la televisión y medios digitales
Transformando dende a universidade: V Xornada Universitaria Galega en Xénero, XUGeX